This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2023-2025.
Company Filing History:
Years Active: 2023-2025
Title: Gregory S. Keyes: Innovator in Fatty Acid Derivatives and Sensotherapeutics
Introduction
Gregory S. Keyes is a notable inventor based in Timonium, MD (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of fatty acid derivatives and their applications in treating various medical conditions. With a total of 3 patents to his name, Keyes continues to push the boundaries of innovation in healthcare.
Latest Patents
One of Keyes' latest patents focuses on fatty acid derivatives and their use in pharmaceutical compositions. This patent outlines methods for utilizing these derivatives to treat a range of conditions, including inflammation, chronic pain, autoimmune disorders, and neurodegenerative diseases. The compounds described in this patent have structures that allow for versatility in treatment options.
Another significant patent by Keyes involves Gingerenone A prodrugs, which are designed as sensotherapeutics. These compounds are useful for inhibiting or eliminating senescence and may be administered to individuals suffering from senescence-associated diseases, neuroinflammation, and pain. The innovative structures of these prodrugs highlight Keyes' commitment to addressing complex health issues.
Career Highlights
Gregory S. Keyes works for the United States of America, as represented by the Secretary, Department of Health and Human Services. His role in this esteemed organization allows him to contribute to public health through his innovative research and patent developments.
Collaborations
Keyes has collaborated with notable colleagues, including Christopher E. Ramsden and Luigi Ferrucci. These partnerships enhance the research and development process, fostering an environment of shared knowledge and expertise.
Conclusion
Gregory S. Keyes exemplifies the spirit of innovation in the pharmaceutical industry. His work on fatty acid derivatives and sensotherapeutics showcases his dedication to improving health outcomes through scientific advancement. His contributions are invaluable in the ongoing quest for effective treatments for complex medical conditions.